Stock Scorecard



Stock Summary for Conmed Corp (CNMD) - $57.68 as of 5/5/2025 2:47:47 PM EST

Total Score

15 out of 30

Safety Score

50 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for CNMD

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CNMD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CNMD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CNMD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CNMD (50 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 2
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 9
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for CNMD

CVS Health Posts Better-Than-Expected Earnings, Joins CommScope, Microsoft, Meta, Chart Industries, And Other Big Stocks Moving Higher On Thursday - Advanced Energy Indus ( NASDAQ:AEIS ) , ATI ( NYSE:ATI ) 5/1/2025 3:36:00 PM
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook 5/1/2025 1:13:00 PM
Conmed ( CNMD ) Surpasses Q1 Earnings and Revenue Estimates 4/30/2025 10:00:00 PM
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind 4/14/2025 2:10:00 PM
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now 4/8/2025 10:46:00 AM
Global Bariatric Surgeries Market to Hit USD 27.64 Billion by 2030, Fueled by Rising Demand for Minimally Invasive Techniques - The Insight Partners 4/1/2025 2:23:00 PM
Conmed ( CNMD ) Down 12.2% Since Last Earnings Report: Can It Rebound? 3/7/2025 4:30:00 PM
Conmed ( CNMD ) Down 12.2% Since Last Earnings Report: Can It Rebound? 3/7/2025 3:30:00 PM
New Strong Sell Stocks for February 19th 2/19/2025 10:15:00 AM
New Strong Sell Stocks for February 11th 2/11/2025 10:12:00 AM

Financial Details for CNMD

Company Overview

Ticker CNMD
Company Name Conmed Corp
Country USA
Description CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company is headquartered in Largo, Florida.
Sector Name LIFE SCIENCES
Industry Name ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Most Recent Quarter 3/31/2025
Next Earnings Date 7/29/2025

Stock Price History

Last Day Price 57.68
Price 4 Years Ago 137.62
Last Day Price Updated 5/5/2025 2:47:47 PM EST
Last Day Volume 694,832
Average Daily Volume 565,048
52-Week High 77.67
52-Week Low 46.00
Last Price to 52 Week Low 25.39%

Valuation Measures

Trailing PE 14.95
Industry PE 25.29
Sector PE 37.03
5-Year Average PE 37.37
Free Cash Flow Ratio 50.16
Industry Free Cash Flow Ratio 23.51
Sector Free Cash Flow Ratio 29.42
Current Ratio Most Recent Quarter 2.26
Total Cash Per Share 1.15
Book Value Per Share Most Recent Quarter 31.61
Price to Book Ratio 1.83
Industry Price to Book Ratio 3.16
Sector Price to Book Ratio 21.93
Price to Sales Ratio Twelve Trailing Months 1.34
Industry Price to Sales Ratio Twelve Trailing Months 2.88
Sector Price to Sales Ratio Twelve Trailing Months 28.34
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 30,939,900
Market Capitalization 1,784,613,432
Institutional Ownership N/A

Dividends

Ex-Dividend Date 3/14/2025
Previous Dividend Amount 0.2000
Current Dividend Amount 0.2000
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.80
Trailing Annual Dividend Yield 1.40%
Forward Annual Dividend Rate 0.80
Forward Annual Dividend Yield 1.40%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 1.17%
5-Year Average Dividend Yield 0.85%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 2.43%
Dividend Payout Ratio 18.82%

Income Statement

Quarterly Earnings Growth YOY -69.80%
Annual Earnings Growth 105.44%
Reported EPS 12 Trailing Months 3.81
Reported EPS Past Year 0.95
Reported EPS Prior Year 4.16
Net Income Twelve Trailing Months 118,751,000
Net Income Past Year 132,423,000
Net Income Prior Year 64,459,000
Quarterly Revenue Growth YOY 2.90%
5-Year Revenue Growth 6.47%
Operating Margin Twelve Trailing Months 7.27%

Balance Sheet

Total Cash Most Recent Quarter 35,485,000
Total Cash Past Year 24,459,000
Total Cash Prior Year 24,296,000
Net Cash Position Most Recent Quarter -855,958,000
Net Cash Position Past Year -880,607,000
Long Term Debt Past Year 905,066,000
Long Term Debt Prior Year 973,140,000
Total Debt Most Recent Quarter 891,443,000
Equity to Debt Ratio Past Year 0.52
Equity to Debt Ratio Most Recent Quarter 0.52
Total Stockholder Equity Past Year 962,681,000
Total Stockholder Equity Prior Year 834,222,000
Total Stockholder Equity Most Recent Quarter 977,636,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 164,553,000
Free Cash Flow Per Share Twelve Trailing Months 5.32
Free Cash Flow Past Year 153,884,000
Free Cash Flow Prior Year 106,316,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -1.79
MACD Signal -2.44
20-Day Bollinger Lower Band 48.58
20-Day Bollinger Middle Band 61.80
20-Day Bollinger Upper Band 75.02
Beta 1.19
RSI 54.27
50-Day SMA 67.18
150-Day SMA 86.74
200-Day SMA 97.69

System

Modified 5/5/2025 9:02:00 PM EST